Alternatives
Alternatives to Imuldosa 90 mg/1 mL injection
There are 9 alternatives to this medicine in the catalogue: the same active ingredient (Ustekinumab), strength (90 mg/1 mL) and dosage form (injection) from 9 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Imuldosa 90 mg/1 mL injectionThis pageSubcutaneous | Accord BioPharmaIndia | US FDA | 1 blister pack of 1 mL | Cold chain | On request | — | Available on request |
| Ustekinumab 90 mg/1 mL injectionSubcutaneous | — | US FDA | 1 tray of 1 mL, 1 tray of 1 mL | Cold chain | On request | — | Available on request |
| Pyzchiva 90 mg/1 mL injectionSubcutaneous | Cordavis | US FDA | 1 syringe of 1 mL, 1 syringe of 1 mL | Cold chain | On request | — | Available on request |
| Wezlana 90 mg/1 mL injectionSubcutaneous | Nuvaila | US FDA | 1 syringe of 1 mL, 1 syringe of 1 mL | Cold chain | On request | — | Available on request |
| Otulfi 90 mg/1 mL injectionSubcutaneous | Fresenius Kabi | US FDA | 1 syringe of 1 mL | Cold chain | On request | — | Available on request |
| Selarsdi 90 mg/1 mL injectionSubcutaneous | Teva Pharmaceuticals | US FDA | 1 tray of 1 mL | Cold chain | On request | — | Available on request |
| Starjemza 90 mg/1 mL injectionSubcutaneous | Hikma Pharmaceuticals | US FDA | 1 mL | Cold chain | On request | — | Available on request |
| Stelara 90 mg/1 mL injectionSubcutaneous | Janssen Biotech | US FDA | 1 syringe of 1 mL | Cold chain | On request | — | Available on request |
| Steqeyma 90 mg/1 mL injectionSubcutaneous | Celltrion | US FDA | 1 syringe of 1 mL | Cold chain | On request | — | Available on request |
| Yesintek 90 mg/1 mL injectionSubcutaneous | Biocon BiologicsIndia | US FDA | 1 syringe of 1 mL | — | On request | — | Available on request |
This is a biological medicine. Products from other makers are biosimilars, not identical copies, and switching between them follows the prescriber's and regulator's rules.
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Imuldosa 90 mg/1 mL injectionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.